What's Happening?
NHS England has announced the commencement of testing for a prototype single national formulary (SNF) by June 2026. This initiative was revealed at the Clinical Pharmacy Congress 2026 in London. The SNF aims to standardize the process of prescribing medicines
across England, addressing the current 'postcode lottery' where access to medicines varies by location. The test phase will include the development of draft national guidance for local formulary standardization, with decisions in therapeutic areas expected to be released starting July 2026. The SNF will be integrated into clinical workloads and prescribing systems as a digital product, while maintaining clinicians' freedom to prescribe based on patient needs. The final national guidance is anticipated by December 2026, with a full digital tool launch in July 2027.
Why It's Important?
The introduction of a single national formulary is significant as it seeks to eliminate disparities in medicine access across different regions in England. Currently, the localized approach to formularies results in inconsistent availability of medicines, which can affect patient outcomes. By standardizing this process, the NHS aims to ensure that all patients have timely access to necessary medications, regardless of their location. This could lead to improved health outcomes and a more equitable healthcare system. The SNF also emphasizes value and outcome over price, potentially leading to more cost-effective healthcare delivery. The initiative reflects a broader trend towards digital integration in healthcare, which could streamline operations and improve efficiency.
What's Next?
Following the test phase, the NHS plans to release the SNF digital tool in July 2027, initially covering a select range of therapeutic areas. By 2030, the tool is expected to expand to include more medicines and medical technologies. The success of the SNF will be measured by improved patient access to medicines. Stakeholders, including clinicians and patients, will likely be involved in ongoing evaluations to ensure the formulary meets its objectives. The NHS will need to address any challenges that arise during the implementation phase, such as ensuring the digital tool is user-friendly and effectively integrated into existing systems.
